[1]
|
Seagle Brandon-Luke, L., Kanis, M., Strohl, A.E., et al. (2016) Survival of Women with Mullerian Adenosarcoma: A National Cancer Data Base Study. Gynecologic Oncology, 143, 636-641. https://doi.org/10.1016/j.ygyno.2016.10.013
|
[2]
|
Nathenson, M.J. and Conley, A.P. (2018) Prognostic Factors for Uterine Adenosarcoma: A Review. Expert Review of Anticancer Therapy, 18, 1093-1100. https://doi.org/10.1080/14737140.2018.1518136
|
[3]
|
杨元元, 刘俊玲, 李娟, 赵利敏, 王志永, 刘晓博, 岳伶俐. 子宫腺肉瘤伴肉瘤样过度生长的临床病理分析[J]. 临床与实验病理学杂志, 2018(1): 69-72.
|
[4]
|
Clement, P.B. and Scully, R.E. (1974) Müllerian Adenosarcoma of the Uterus. A Clinicopathologic Analysis of Ten Cases of a Distinctive Type of Müllerian Mixed Tumor. Cancer, 34, 1138-1149.
https://doi.org/10.1002/1097-0142(197410)34:4<1138::AID-CNCR2820340425>3.0.CO;2-9
|
[5]
|
Arend, R., Bagaria, M., Lewin, S.N., et al. (2010) Long-Term Outcome Andnatual History of Uterine Adenosarcomas. Gynecologic Oncology, 119, 305-308. https://doi.org/10.1016/j.ygyno.2010.07.001
|
[6]
|
Nathenson, M.J., Ravi, V., Fleming, N., et al. (2016) Uterine Adenosarcoma: A Review. Current Oncology Reports, 18, 68-78. https://doi.org/10.1007/s11912-016-0552-7
|
[7]
|
曲文洁. 基于深度学习的子宫腺肉瘤个性化生存预测模型的开发和验证[D]: [硕士学位论文]. 济南: 山东大学, 2021. https://doi.org/10.27272/d.cnki.gshdu.2021.001262
|
[8]
|
Akhavan, A., Tafti, M.A., Aghili, F., et al. (2012) Uterine Adenosarcoma in a Patient with History of Breast Cancer and Long-Term Tamoxifen Consumption. BMJ Case Reports, 2012, bcr2012006590.
https://doi.org/10.1136/bcr-2012-006590
|
[9]
|
Chin, P.S., Chia, Y.N., Lim, Y.K., Yam, K.L., et al. (2013) Diagno-sis and Management of Müllerian Adenosarcoma of the Uterine Cervix. International Journal of Gynecology & Obstet-rics, 121, 229-232.
https://doi.org/10.1016/j.ijgo.2012.12.015
|
[10]
|
Sarat, K., et al. (2014) Vaginal Mass in a 13-Year-Old Girl. Annals of the Academy of Medicine Singapore, 43, 127-129. https://doi.org/10.47102/annals-acadmedsg.V43N2p127
|
[11]
|
Carroll, A., Ramirez, P.T., Westin, S.N., et al. (2014) Uterine Adenosarcoma: An Analysis on Management, Outcomes, and Risk Factors for Recurrence. Gynecologic Oncol-ogy, 135, 455-461. https://doi.org/10.1016/j.ygyno.2014.10.022
|
[12]
|
Machida, H., Nathenson, M.J., Takiuchi, T., et al. (2017) Significance of Lymph Node Metastasis on Survival of Women with Uterine Adenosarcoma. Gynecologic Oncology, 144, 524-530.
https://doi.org/10.1016/j.ygyno.2017.01.012
|
[13]
|
Kudela, E., Nachajova, M., Balharek, T., et al. (2019) Mullerian Adenosarcomas of the Uterine Cervix with Sarcomatous Overgrowth. Current Problems in Cancer, 43, 371-376. https://doi.org/10.1016/j.currproblcancer.2018.11.002
|
[14]
|
Shinichi, T., et al. (2018) Clinical Management of Uter-ine Cervical Mullerian Adenosarcoma: A Clinicopathological Study of Six Cases and Review of the Literature. Taiwan-ese Journal of Obstetrics & Gynecology, 57, 497-482.
https://doi.org/10.1016/j.tjog.2018.04.032
|
[15]
|
Soslow, R.A., Ali, A. and Oliva, E. (2008) Muiierian Adenosarco-mas: An Immunophenotypic Analyisi of 35 Cases. The American Journal of Surgical Pathology, 32, 1013-1021. https://doi.org/10.1097/PAS.0b013e318161d1be
|
[16]
|
Wang, B., Yang, H.-D., Shi, X.-H., et al. (2019) Advanced Uterine Adenosarcoma with Sarcomatous Overgrowth in a Young Woman: A Case Report. Medicine, 98, e18119. https://doi.org/10.1097/MD.0000000000018119
|
[17]
|
Goh, C., Lin, X.-H., Chin, P.S., et al. (2018) Uterine Preservation in a Young Patient with Adenosarcoma of the Uterus—Case Report and Review of Literature. Gynecologic Oncology Reports, 25, 27-29.
https://doi.org/10.1016/j.gore.2018.05.002
|
[18]
|
于观春. 子宫肉瘤的临床病理特征与预后影响因素的分析[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2021.
https://doi.org/10.27433/d.cnki.gxyku.2021.000439
|
[19]
|
Tanner, E.J., Toussaint, T., Leitao, M.M., et al. (2012) Management of Uterine Adenosarcomas with and without Sarcomatous Overgrowth. Gynecologic Oncology, 129, 140-144. https://doi.org/10.1016/j.ygyno.2012.12.036
|
[20]
|
梁金晓, 林仲秋. 《FIGO 2018癌症报告》——子宫肉瘤诊治指南解读[J]. 中国实用妇科与产科杂志, 2018, 34(12): 1366-1371.
|
[21]
|
谢玲玲, 林荣春. 《2020 NCCN子宫肿瘤临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2020, 36(4): 333-339.
|